ArdorComm Media Group

Saturday, November 8, 2025 6:20 PM

COVID-19 Vaccine

No Proven Link Between COVID-19 Vaccines and Sudden Deaths, Confirms Union Health Ministry

The Union Ministry of Health and Family Welfare has clarified that there is no scientific evidence connecting COVID-19 vaccination with sudden or unexplained deaths in India. This conclusion is backed by comprehensive studies conducted by the Indian Council of Medical Research (ICMR) and the National Centre for Disease Control (NCDC). In an official statement, the Ministry emphasized that extensive investigations were carried out across the country by multiple research agencies to examine reports of sudden deaths, particularly among seemingly healthy young adults. Findings from these studies have consistently shown no direct association between COVID-19 vaccines and such fatalities. Two key studies have been pivotal in reaching this conclusion. The first, undertaken by ICMR’s National Institute of Epidemiology (NIE), is a multicentric matched case-control study titled “Factors associated with unexplained sudden deaths among adults aged 18–45 years in India.” Conducted across 47 tertiary hospitals in 19 states and union territories from May to August 2023, the research analyzed cases between October 2021 and March 2023. The outcome was clear: COVID-19 vaccination does not increase the risk of sudden death in young, otherwise healthy adults. The second study, still in progress, is being led by AIIMS, New Delhi, with ICMR’s collaboration and support. This prospective research—“Establishing the cause in sudden unexplained deaths in young”—aims to pinpoint the most common reasons behind such fatalities. Preliminary data reveals that heart attacks (myocardial infarctions) remain the leading cause of sudden death in this demographic, with no significant shift in trends compared to previous years. In many cases, genetic factors have also emerged as likely contributors. These studies offer valuable insights into sudden deaths among young individuals and provide reassurance about the safety of COVID-19 vaccines. Researchers highlight that deaths may stem from a range of issues, including underlying health conditions, genetic predispositions, and unhealthy lifestyles, rather than vaccination. Public health experts have strongly criticized unverified claims linking vaccines to sudden deaths, calling them unscientific and dangerous. Such misinformation not only lacks factual basis but also poses a serious risk to public trust and could foster vaccine hesitancy, undermining one of the most effective tools used during the pandemic to save lives. The government reaffirmed its commitment to science-driven public health policies and continued research to safeguard the health and well-being of all citizens. Source: ANI

No Proven Link Between COVID-19 Vaccines and Sudden Deaths, Confirms Union Health Ministry Read More »

Alnylam Pharmaceuticals to Appeal Patent Ruling Over Moderna’s COVID Vaccine Technology

Alnylam Pharmaceuticals has announced its intention to challenge a recent decision from the U.S. District Court in Delaware regarding two patents that were brought into question in relation to Moderna’s COVID-19 vaccine, Spikevax. Alnylam, headquartered in Cambridge, Massachusetts, had previously filed lawsuits against both Moderna and Pfizer Inc in Delaware last year, seeking compensation for the use of lipid nanoparticle (LNP) technology in their vaccines, which facilitates the delivery of mRNA, a crucial component of the vaccines. These cases are part of a broader trend of patent disputes arising from the technology underpinning COVID-19 vaccines, including a lawsuit filed by Moderna against Pfizer last year. Although Alnylam and Moderna had previously reached an agreement on the non-infringement of two patents, Alnylam is now contesting the court’s recent decision, indicating its intent to proceed with a second lawsuit against Moderna for patent infringement in the Delaware Court. Moderna has not yet responded to requests for comment on this matter. Importantly, the court’s ruling in Delaware has no bearing on Alnylam’s patent infringement claims against Pfizer in two separate cases.

Alnylam Pharmaceuticals to Appeal Patent Ruling Over Moderna’s COVID Vaccine Technology Read More »